IP Library Granted Patent US 11,484,649
Granted Patent B2
US 11,484,649 · App. 16/887,133 · Granted Nov 1, 2022

Valve assembly for drug delivery device

Inventors: Margarita Falkovich (Paramus, NJ); Venkateswaran Santhanam (Newark, DE); Peter Skutnik (Midland Park, NJ)
Assignee: Becton, Dickinson and Company
A61M5/16813A61M5/1454A61M5/14244A61M39/22A61M2005/14252A61M2205/0266
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,649
App. No.
16/887,133
Granted
Nov 1, 2022
Kind
B2
Abstract

A valve assembly for a drug delivery device includes a valve housing having a first side and a second side positioned opposite from the first side, a cannula having a first end and a second end positioned opposite the first end, a pierce plate having a body and a piercing member extending from the body, with the body defining a coiled elongate member, and a valve boot connected to the valve housing and defining an interior space. The valve boot is configured to move from a pre-use position where the first end of the cannula and the piercing member of the pierce plate are received within the interior space to a use position where the piercing member of the pierce plate and the first end of the cannula extend outside of the valve boot and the interior space.

Claims (24)

1. A valve assembly for a drug delivery device, the valve assembly comprising:

a valve housing having a first side and a second side positioned opposite from the first side;

a cannula having a first end and a second end positioned opposite the first end, the cannula defining a central passageway;

a valve boot connected to the valve housing and defining an interior space, the valve boot is configured to move from a pre-use position where the first end of the cannula is received within the interior space to a use position where the first end of the cannula extends outside of the valve boot and the interior space; and

a valve sleeve defining a cannula space, the valve sleeve is configured to move from a pre-use position where the first end of the cannula is received within the cannula space to a use position where the first end of the cannula extends outside of the valve sleeve and the cannula space,

wherein the valve sleeve is positioned within the interior space defined by the valve boot.

2. The valve assembly of claim 1 , wherein the valve sleeve comprises an elastomeric material.

3. The valve assembly of claim 1 , wherein the valve sleeve comprises a first cylindrical portion having a convex tip, a second portion extending from the first portion, and a third frustoconical portion extending from the second portion.

4. The valve assembly of claim 3 , wherein the second portion of the valve sleeve comprises a frustoconical section and a cylindrical section.

5. The valve assembly of claim 3 , wherein the third portion of the valve sleeve comprises at least one recessed portion configured to facilitate a collapse and deformation of the valve sleeve.

6. The valve assembly of claim 1 , wherein the valve sleeve comprises a rubber material.

7. The valve assembly of claim 1 , wherein the valve boot comprises an elastomeric material.

8. The valve assembly of claim 1 , further comprising a pierce plate comprising a body and a piercing member extending from the body, wherein the piercing member of the pierce plate is received within the interior space of the valve boot when the valve boot is in the pre-use position, and wherein the piercing member of the pierce plate extends outside of the valve boot and the interior space when the valve boot is in the use position.

9. A drug delivery device comprising:

a housing;

a cartridge received within the housing, the cartridge configured to receive a medicament;

a drive assembly received within the housing and configured to engage the cartridge and dispense medicament from the cartridge;

a needle actuator assembly received within the housing, the needle actuator assembly comprising a patient needle configured to pierce a patient's skin; and

a valve assembly, comprising:

a valve housing having a first side and a second side positioned opposite from the first side,

a cannula having a first end and a second end positioned opposite the first end, the cannula defining a central passageway,

a valve boot connected to the valve housing and defining an interior space, the valve boot is configured to move from a pre-use position where the first end of the cannula is received within the interior space to a use position where the first end of the cannula extends outside of the valve boot and the interior space, and

a valve sleeve defining a cannula space, the valve sleeve is configured to move from a pre-use position where the first end of the cannula is received within the cannula space to a use position where the first end of the cannula extends outside of the valve sleeve and the cannula space,

wherein the valve sleeve is positioned within the interior space defined by the valve boot.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2020
From: SKUTNIK, PETER
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 053059/0575 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2020
From: FALKOVICH, MARGARITA; SANTHANAM, VENKATESWARAN
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 052791/0695 →
Continuity (2)
Provisional Application 62854587 · May 30, 2019
Related Publication 20200376195A1 · Dec 3, 2020
Cited By (1)
US 12,629,474